Delivery Order SPE2DB20D1100-SPE2DB25FA2M9

Award Date 1/24/25
Potential Completion Date 1/27/25
Potential Value $3.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is valued at $6,135.81. The contract was awarded by the Defense Logistics Agency (DLA) and includes the delivery of 4566861414 ! VEVYE 0.1% EYE DROP 2ML medical products. The contract is a Firm Fixed Price Delivery Order, with a completion date of January 8, 2025. This award is not associated with a set-aside program. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, a Delivery Order contract worth $40,481.51 for the supply of MIEBO 100% eye drops. This contract has a completion date of May 30, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,987.91 fixed-price delivery order is for the provision of MIEBO 100% Eye Drop 3ML medical supplies, with an ultimate completion date of December 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,425.78 firm fixed-price delivery order is for 4567084895 ! MIEBO 100% EYE DROP 3ML medical supplies. The contract has an ultimate completion date of January 30, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,780.33, is a Firm Fixed Price Delivery Order for the supply of MIEBO 100% EYE DROP 3ML medical products. The contract has an ultimate completion date of January 8, 2025 and was awarded on January 7, 2025. The contract was not set aside for any specific business type. Amerisourcebergen holds...
This federal contract award, valued at $8,173.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for the supply of 4564310851 ! VEVYE 0.1% EYE DROP 2ML, with a firm fixed price and an ultimate completion date of April 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This federal contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $84,983.95 firm fixed-price delivery order is for 4567090326 ! MIEBO 100% EYE DROP 3ML, with a performance period through January 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is a firm fixed price delivery order worth $14,390.05, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The award is for the supply of a pharmaceutical product, "VEVYE 0.1% EYE DROP 2ML," with a period of performance through April 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and this award is associated with a larger indefinite delivery contract (IDC) with DLA valued...
This federal contract award, valued at $1,182.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of pharmaceutical products, specifically 4565597435 ! XDEMVY 0.25% DROP 10ML. The contract has an ultimate completion date of September 18, 2024. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA Troop...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract ID is SPE2DB20D3505|SPE2DB25FT2F6 and it is a $2,449.64 firm fixed price delivery order for the supply of "VEVYE 0.1% EYE DROP 2ML" pharmaceutical products. The contract has an ultimate completion date of October 11, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this contract as well as multiple Indefinite...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FA2M9
    Delivery Order

This federal contract award, valued at $3,564.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for VEVYE 0.1% eye drops (2ML) and has a firm fixed price. The award is not associated with a set-aside designation, indicating open competition.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

Generated 4/27/25, 12:57 AM